Un indicio del éxito del teatro de Juan de la Cueva

Después de resumir la opinión crítica sobre la importancia del teatro de Juan de la Cueva en el nacimiento de la "comedia nueva", este artículo señala la presencia de algunas líneas de la "Tragedia de los siete infantes de Lara" en la "Comedia de Roncesvalles ", una comedia manuscrita anónima de la década de 1580. Este descubrimiento demuestra que el teatro de Juan de la Cueva no era tan marginal como se ha pensado y que algunos pasajes dramatizados por el escritor sevillano podrían haber ganado gran popularidad entre el público de la época.After summing up critical opinion on the importance of Juan de la Cueva's theatre in the birth of the “comedia nueva”, this article points out the presence of some lines from the “Tragedia de los siete infantes de Lara” in the “Comedia de Roncesvalles”, an anonymous manuscript comedy of the 1580s. This discovery demonstrates that Juan de la Cueva's theatre was not so marginal as has been thought, and that some dramatic passages by the Sevillian playwright might have gained great popularity among the public of the time.notPeerReviewe

Ressenyes

Obra ressenyada: Francesco PETRARCA; edición bilingüe de Guido M. CAPPELLI, Triunfos. Madrid: Cátedra, 2003

Reseñas

Obra ressenyada: Emilio PASCUAL BARCIELA, La anagnórisis en la tragedia española del Renacimiento. Herne: Gabriele Schäfer Verlag, 2016 ; Ismael LÓPEZ MARTÍN, La anagnórisis en la obra dramática de Lope de Vega. Vigo: Academia del Hispanismo, 2017

Lachmann y las acotaciones

This article tackles the problem of editing the stage directions from a neo-Lachmannian point of view. After considering the nature of the stage direction a sign within the semiotic nature of the theatrical text, the behaviour of the copyists in the manuscript and printed transmission of the Spanish theatre of the Golden Age is taken into account, in order to analyse those problems that arise in the application of the method in the phase of constitutio textus. Thus, the focus is on four paradigmatic cases: variants stemming from different staging; variants within a recensio cum stemmate; variants in a contaminatio; lack of stage directions either in one-witness traditions or in the archetype

La biblioteca de Gondomar y la ilusoria búsqueda del eslabón perdido

Presentación: La biblioteca de Gondomar y la ilusoria búsqueda del eslabón perdidoPresentation: The Gondomar Library and the Illusory Quest For the Missing Lin

Chapter Introducción. La ecdótica de los textos teatrales del Siglo de Oro entre la praxis y la teoría

undefine

[Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]

 BACKGROUND: Peginterferon beta-1a, injected every two weeks, is the first approved pegylated interferon beta-1a for the treatment of relapsing remitting multiple sclerosis (RRMS). The objective of this analysis was to estimate the economic impact due to the introduction of peginterferon beta-1a in Italy.METHODS: This analysis was conducted with a three-year time horizon with the support of a simple decision-analytic model adopting the perspective of the Italian National Healthcare Service (NHS). Healthcare costs sustained by the Italian NHS to manage the RRMS population (drug treatment, monitoring, relapse management, adverse events management) were calculated over 3 years and compared in two scenarios: the base scenario where interferons-beta and glatiramer acetate (GA) are used to treat RRMS patients, and an alternative scenario where peginterferon beta-1a can also be used to treat RRMS patients. The target population was approximately 35,500, 37,500 and 39,500 patients at year 1, 2 and 3 respectively, based on the published literature and market data. The efficacy of treatments was simulated as a reduction of relapse rates and was derived from a Network Meta-analysis. Unit costs were based on current prices and tariffs, and the published literature. A one-way sensitivity analysis was developed.RESULTS: According to current price and described assumptions, it was estimated that the introduction of peginterferon beta-1a would result in a decrease of total costs when compared with the base scenario. The cost in the base scenario was estimated to be  € 321.5, € 339.7 and € 357.8 million in years 1, 2, and 3, respectively. In the alternative scenario, the same costs resulted in about € 321.1, € 338.6 and € 356.2 million, respectively. The cumulative budget impact over three years period was approximately a cost saving of € 3.1 million (about 0.3% saving).CONCLUSION: The adoption of peginterferon beta-1a for the treatment of RRMS would be viewed as economically sustainable by the Italian NHS.[Article in Italian